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Artichoke, borututu and milk thistle are three medicinal plants well-known for their 
capacity to prevent oxidative stress and many liver diseases. In a previous work, we 
reported the bioactivity of infusions and pills based on these plants; herein, the aim was 
to provide scientific information about the antioxidant and anti-hepatocellular 
carcinoma activities of syrups based on these medicinal plants and evaluate the 
synergism among the combined plants by using syrups based on the mixed plants or 
prepared form the combinations of individual species. The antioxidant activity was 
measured by radical scavenging activity, reducing power and lipid peroxidation 
inhibition, while the anti-hepatocellular carcinoma activity and the hepatotoxicity were 
evaluated using HepG2 human cell line and a primary culture of porcine liver cells, 
respectively. Milk thistle syrup proved to have the highest antioxidant activity in all the 
assayed methods, providing the best results either in single syrup or included in mixed 
syrups. Synergistic effects were the main interactions observed in the mixture of 
artichoke, borututu and milk thistle; mixing the syrups based on each single plant 
proved to be more efficient regarding antioxidant proposals than mixing plants in the 
same syrup. The latter was advantageous for anti-hepatocellular carcinoma activity. 
 















Medicinal plants are increasingly perceived as a source of biologically active 
compounds with beneficial effects in human health that may be included in the 
treatment of many diseases as new therapeutics or as foundations for the development 
of new drugs (Cragg and Newman, 2013). Nevertheless, their prevalent use and easy 
availability has raised concerns over their quality, efficacy and safety (Campos et al., 
1089). Indeed, the chemical composition of these plants is not constant and the presence 
of chemicals that claims to have medicinal benefits (active principals) depends on a 
number of factors including the plant species, the time and season of harvest, the type of 
soil, the way the herb is prepared, etc. (Ferreres et al., 2013).  
In order to contour the problem of standardization of the chemical composition of herbs 
and also due to the significant toxic effects in humans that the misidentification or the 
mislabeling can lead to, medicinal plants can be processed to become a dietary 
supplement that contains well-defined and constant composition (Bauer, 1998; Kunle et 
al., 2012; Liang et al., 2004). 
Cynara scolymus L. (artichoke), Cochlospermum angolensis Welw. (borututu) and 
Silybum marianum (L.) Gaertn (milk thistle) are three medicinal plants well-known for 
their capacity to prevent oxidative stress and many liver diseases (Fehér et al., 1990; 
Campos et al., 1089; Ferreres et al., 2013; Adzet et al., 1987; Gebhardt, 1997). Several 
formulations based on the mentioned plants are available on market, such as infusions, 
pills, capsules and syrups, among others. The infusions and pills, which are the most 
commonly used, were previously assessed by our research group and proved to have 
antioxidant and anti-hepatocellular carcinoma activity (Pereira et al., 2013). 
Nevertheless, as far as we know, nothing has been reported on syrups. In fact, due to its 
high concentration, syrups based on those plants are also considered very useful 
formulations containing not only each species, but also different combinations of the 
three medicinal plants.  
Nowadays, studies involving the evaluation of synergistic effects of combined plants 
are emerging and seem to highlight the potential of the mixtures when compared with 
the isolated plants (Almeida et al., 2011; Sidhu et al., 2009; Singha et al., 2011).  
Thus, given the extensive use of artichoke, milk thistle and borututu as antioxidants and 
hepatoprotective, the present study aimed to provide scientific information about the 
bioactivity of syrups (antioxidant and anti-hepatocellular carcinoma activities) based on 
these medicinal plants. Furthermore, synergism among the combined in detriment to the 
isolated plants was also evaluated by using syrups based on the mixed plants or 
prepared form the combinations of individual species.  
 
2. Material and Methods 
 
2.1. Samples and samples preparation 
Cynara scolymus L. (artichoke), Silybum marianum (L.) Gaertn (milk thistle) and 
Cochlospermum angolensis Welw. (borututu) were obtained from an herbalist shop in 
Bragança (Portugal) as syrups. According to the label information, artichoke syrup (AS) 
is a dietary supplement containing 100% of artichoke, water and preservative (methyl p-
hydroxybenzoate); borututu syrup (BS) contains 10% of borututu roots, acidity 
regulator (citric acid), preservatives (potassium sorbate, sodium benzoate and propyl 
gallate) and sweeteners (aspartame, sodium cyclamate and saccharin); milk thistle syrup 
(MS) consists of 2.3% of milk thistle, sea buckthorn, carriers (fructose, water), 
sweetener (sorbitol), thickening agents (guar and locust bean gum), preservative 
(potassium sorbate), acidifying (L-ascorbic acid), stabilizer (pectin). Lastly, (A+B+M)S 
is based on hydrophilic extracts of milk thistle (plant) 35%, borututu (plant) 15%, 
artichoke (plant) 15%, and sweetener (sodium saccharin). 
The concentration of the plant in the syrups was obtained from the recommended daily 
dose: AS at 1000 mg/mL, BS at 100 mg/mL and MS at 26.4 mg/mL.  A syrup with the 
three plants (artichoke and borututu at 150 mg/mL and milk thistle at 350 mg/mL; 
(A+B+M)S) was also obtained in the same shop. Lastly, a mixture with the syrups of 
each sample (AS+BS+MS) was prepared at the same concentrations previously 
mentioned for the syrup with the three plants. According to the mentioned 
concentrations, the percentage of each plant in the mixture corresponds to 23% for 
artichoke, 23% for borututu and 54% for milk thistle (these percentages were used for 
classification of synergistic and antagonist effects on the bioactive properties assayed). 
The five different syrups (AS, BS, MS, (A+B+M)S and AS+BS+MS; stock solutions) 
were successively diluted and submitted to an evaluation of antioxidant activity, anti-
hepatocellular carcinoma activity and hepatotoxicity.  
 
2.2. Standards and reagents 
2,2-Diphenyl-1-picrylhydrazyl (DPPH) was obtained from Alfa Aesar (Ward Hill, 
USA). Gallic acid, catechin, trolox (6-hydroxy-2,5,7,8-tetramethylchroman-2-
carboxylic acid), ellipticine, phosphate buffered saline (PBS), acetic acid, 
sulforhodamine B (SRB), trichloroacetic acid (TCA) and Tris were purchased from 
Sigma (St. Louis, USA). Foetal bovine serum (FBS), L-glutamine, Hank’s balanced salt 
solution (HBSS), trypsin-EDTA (ethylenediaminetetraacetic acid), nonessential amino 
acids solution (2 mM), penicillin/streptomycin solution (100 U/mL and 100 mg/mL, 
respectively) and DMEM (Dulbecco's Modified Eagle Medium) were from Hyclone 
(Logan, USA). Water was treated in a Milli-Q water purification system (TGI Pure 
Water Systems, USA).  
 
2.3. Evaluation of antioxidant activity  
The antioxidant properties were evaluated by four different tests: DPPH radical-
scavenging activity, reducing power, inhibition of β-carotene bleaching and inhibition 
of lipid peroxidation using TBARS (thiobarbituric acid reactive substances) in brain 
homogenates (Pereira et al., 2013). The results were expressed in EC50 values (sample 
concentration providing 50% of antioxidant activity or 0.5 of absorbance in the reducing 
power assay). Trolox was used as positive control. 
 
2.3.1. DPPH radical-scavenging activity. This methodology was performed using an 
ELX800 microplate Reader (Bio-Tek Instruments, Inc; Winooski, USA). The reaction 
mixture on 96 well plate consisted in the sample solutions (30 µL) and methanolic 
solution (270 µL) containing DPPH radicals (6×10-5 mol/L). The mixture was left to 
stand for 30 min in the dark, and the absorption was measured at 515 nm. The radical 
scavenging activity (RSA) was calculated as a percentage of DPPH discoloration using 
the equation: %RSA=[(ADPPH-AS)/ADPPH]×100, where AS is the absorbance of the 
solution containing the sample, and ADPPH is the absorbance of the DPPH solution. 
 
2.3.2. Reducing power. The sample solutions (0.5 mL) were mixed with sodium 
phosphate buffer (200 mmol/L, pH 6.6, 0.5 mL) and potassium ferricyanide (1% w/v, 
0.5 mL). The mixture was incubated at 50 °C for 20 min, and trichloroacetic acid (10% 
w/v, 0.5 mL) was added. The mixture (0.8 mL) was poured in the 48 wells plate, the 
same with deionised water (0.8 mL) and ferric chloride (0.1% w/v, 0.16 mL), and the 
absorbance was measured at 690 nm in the Microplate Reader mentioned above. 
 
2.3.3. Inhibition of β-carotene bleaching. A solution of β-carotene was prepared by 
dissolving β-carotene (2 mg) in chloroform (10 mL). Two milliliters of this solution 
were pipetted into a round-bottom flask. The chloroform was removed at 40 °C under 
vacuum and linoleic acid (40 mg), Tween 80 emulsifier (400 mg), and distilled water 
(100 mL) were added to the flask with vigorous shaking. Aliquots (4.8 mL) of this 
emulsion were transferred into test tubes containing sample solutions (0.2 mL). The 
tubes were shaken and incubated at 50 °C in a water bath. As soon as the emulsion was 
added to each tube, the zero time absorbance was measured at 470 nm. β-Carotene 
bleaching inhibition was measured by the formula: β-carotene absorbance after 
2h/initial absorbance) × 100.  
 
2.3.4. TBARS assay. Porcine (Sus scrofa) brains were obtained from official slaughtered 
animals, dissected, and homogenized with Polytron in an ice cold Tris-HCl buffer (20 
mM, pH 7.4) to produce a 1:2 w/v brain tissue homogenate which was centrifuged at 
3000g for10 min. An aliquot (100 µL) of the supernatant was incubated with the sample 
solutions (200 µL) in the presence of FeSO4 (10 mM; 100 µL) and ascorbic acid (0.1 
mM; 100 µL) at 37 °C for 1h. The reaction was stopped by the addition of 
trichloroacetic acid (28% w/v, 500 µL), followed by thiobarbituric acid (TBA, 2%, w/v, 
380 µL), and the mixture was then heated at 80 °C for 20 min. After centrifugation at 
3000g for 10 min to remove the precipitated protein, the color intensity of the 
malondialdehyde (MDA)-TBA complex in the supernatant was measured by its 
absorbance at 532 nm. The inhibition ratio (%) was calculated using the following 
formula: Inhibition ratio (%) = [(A−B)/A] × 100%, where A and B were the absorbance 
of the control and the sample solution, respectively. 
 
2.4. Evaluation of hepatocellular carcinoma activity 
The anti-hepatocellular carcinoma activity was evaluated using HepG2, which is the 
most widely used tumour cell line and generally regarded as a good hepatocellular 
carcinoma model. HepG2 cells were routinely maintained as adherent cell cultures in 
DMEM supplemented with 10% FBS, 2 mM glutamine, 100 U/mL penicillin and 100 
mg/mL streptomycin, at 37 ºC, in a humidified air incubator containing 5% CO2. The 
cell line was plated at 1.0 × 104 cells/well in 96-well plates. Cells were then treated for 
48h with the sample solutions. Following this incubation period, the adherent cells were 
fixed by adding cold 10% trichloroacetic acid (TCA, 100 µL) and incubated for 60 min 
at 4 ºC. Plates were then washed with deionized water and dried; sulforhodamine B 
solution (0.1% in 1% acetic acid, 100 µL) was added to each plate well and incubated 
for 30 min at room temperature. Unbound SRB was removed by washing with 1% 
acetic acid. Plates were air dried, the bound SRB was solubilised with 10 mM Tris (200 
µL, pH 7.4) and the absorbance was measured at 540 nm (Pereira et al., 2013) in the 
microplate reader mentioned above. The results were expressed in GI50 values (sample 
concentration that inhibited 50% of the net cell growth). Ellipticine was used as positive 
control.  
 
2.5. Evaluation of hepatotoxicity  
The hepatotoxicity was accessed using a non-tumour liver primary culture established in 
our laboratory (PLP2). The cell culture was prepared from a freshly harvested porcine 
liver obtained from a local slaughter house. Once in the lab, the liver tissues were rinsed 
in Hank’s balanced salt solution containing 100 U/mL penicillin, 100 µg/mL 
streptomycin and divided into 1×1 mm3 explants. Five explants were placed in 25 cm2 
tissue flasks in DMEM medium supplemented with 10% FBS, 2 mM nonessential 
amino acids and 100 U/mL penicillin, 100 mg/mL streptomycin and incubated at 37 ºC 
with a humidified atmosphere containing 5% CO2. The medium was changed every two 
days. Cultivation of the cells was continued with direct monitoring every two to three 
days using a phase contrast microscope. Before confluence, cells were subcultured and 
plated in 96-well plates at a density of 1.0×104 cells/well, and cultivated in DMEM 
medium with 10% FBS, 100 U/mL penicillin and 100 µg/mL streptomycin (Guimarães 
et al., 2013). Cells were treated for 48h with the sample solutions and the same 
procedure described in the previous section for SRB assay was followed. The results 
were expressed in GI50 values (sample concentration that inhibited 50% of the net cell 
growth). Ellipticine was used as positive control. 
 
2.6. Classification of additive, synergistic or antagonistic effects  
Theoretical values for antioxidant activity of the mixtures were calculated as weighted 
mean experimental EC50 values (available in Table 1) and considering additive 
contributions of individual species in each percentage: EC50 = EC50AS×0.23 + 
EC50BS×0.23 + EC50MS×0.54. The theoretical value for hepatocellular carcinoma 
activity is the EC50MS since AS and BS did not show activity.  
The classification in additive (AD), synergistic (SN) or antagonistic (negative 
synergistic; AN) effects was performed as follow: AD: theoretical and experimental 
values reveal differences lower than 5% (Burtis and Ashwood, 1999; Queirós et al., 
2009); SN: experimental values are more than 5% lower for EC50 when compared with 
theoretical values; AN: experimental values are more than 5% higher for EC50 when 
compared with theoretical values. 
 
2.7. Statistical analysis 
For all the experiments three samples (n=3) were analysed and all the assays were 
carried out in triplicate. The results are expressed as mean values and standard deviation 
(SD). The differences between the different samples were analyzed using one-way 
analysis of variance (ANOVA) followed by Tukey’s honestly significant difference post 
hoc test with α = 0.05, coupled with Welch’s statistic. This treatment was carried out 
using SPSS v. 18.0 program.  
 
3. Results and Discussion 
Artichoke, borututu and milk thistle were assessed either as single plant syrup (AS, BS 
and MS, respectively), in different combinations of each plant in the same syrup 
(AS+BS+MS) or in a mixture of different plant syrups ((A+B+M)S). Free radicals 
scavenging activity, reducing power and lipid peroxidation inhibition were tested to 
evaluate the in vitro antioxidant properties of these syrups, HepG2 human cell line was 
used to assess anti-hepatocellular carcinoma activity, while a primary culture of porcine 
liver cells was established to evaluate hepatotoxicity. The results obtained for individual 
and combined syrups are shown in Tables 1 and 2, respectively.  
MS was the most powerful sample in all the assays: DPPH scavenging activity (0.32 
mg/mL), reducing power (0.05 mg/mL), β-carotene bleaching inhibition (0.02 mg/mL) 
and TBARS inhibition (0.05 mg/mL) followed by BS that also revealed high 
antioxidant activity (0.15 to 1.34 mg/mL). Regarding the hepatocellular carcinoma 
activity, only MS revealed capacity to inhibit the proliferation of HepG2 cell line 
(280.48 µg/mL), despite none of the syrups revealed hepatotoxicity for normal liver 
cells (Table 1). 
In a previous study (Pereira et al., 2013) with artichoke (A), borututu (B) and milk 
thistle (M) infusions and pills, B samples showed the highest antioxidant activity and 
the infusion also revealed anti-hepatocellular carcinoma activity (GI50=146 µg/mL) 
without toxicity in non-tumor liver cells (PLP2), while A infusion showed capacity to 
inhibit the proliferation of HepG2 cell line (GI50=52 µg/mL) but with toxicity for PLP2 
cell culture (GI50=72 µg/mL). Comparing infusions and pills with the syrups studied in 
the present work, the antioxidant activity varies as follows: infusion>pills>syrup, 
infusion>syrup≈pills and syrup>infusion>pills for A, B and M, respectively. 
Besides the syrups based on a single plant there are also available syrups mixing the 
three plants. Our research was guided by three main questions: 1) Are syrups based on 
mixed plants more bioactive than syrups with a single plant? 2) Have the syrups with 
mixed plants the same bioactivity of mixed plant syrups? 3) What are the main effects 
(synergistic, additive or antagonist) in the antioxidant and anti-hepatocellular carcinoma 
activity of the syrups containing the three plants? 
MS proved to have the highest antioxidant activity in all the assayed methods, providing 
the best results among single syrup and even better than mixed syrups. The same 
tendency was observed for BS that gave higher antioxidant properties than mixed 
samples. Therefore, AS was the only sample which is favored by the mixture of plants 
in the same syrup ((A+B+M)S) or by the mixture of syrups based on each plant 
(AS+BS+MS) (Table 2).  
Mixing syrups, AS+BS+MS, allowed higher DPPH scavenging activity (2.16 mg/mL), 
reducing power (0.78 mg/mL) and TBARS inhibition (0.25 mg/mL) than the syrup with 
the three mixed plants, (A+B+M)S. Nevertheless, the latter gave higher β-carotene 
bleaching inhibition (1.36 mg/mL).  
The experimental results of the antioxidant capacity of the mixtures were mostly better 
than the theoretical values (calculated with the results obtained from the individual 
syrups, Table 1) with the exception of β-carotene bleaching inhibition assay applied to 
AS+BS+MS (7.13 > 4.13 mg/mL; Table 2). Thus, the synergistic effects (increase of 
antioxidant capacity) were predominant, being observed in 87.5% of the assays with 
only one experimental EC50 value giving antagonistic effect.  
Regarding the hepatoprotective effect, only (A+B+M)S revealed anti-hepatocellular 
carcinoma activity in HepG2 (342.30 µg/mL), but none of the syrups revealed 
hepatotoxicity in normal cells. Thus, an antagonistic effect of the three plants in 
(A+B+M)S (decrease of anti-hepatocellular carcinoma activity) and in AS+BS+MS (no 
activity) in comparison to MS, was observed. 
There are some studies involving combined natural matrices like different mushrooms, 
dietary supplements (plant pills or capsules) and even plant infusions and decoctions in 
order to achieve synergistic effects in the antioxidant activity. An experiment mixing 
different mushroom species (Boletus edulis, Calocybe gambosa, Cantharellus cibarius, 
Craterellus cornucopioides and Marasmius oreades) revealed that synergism was the 
most abundant effect in the antioxidant properties of the mixtures and that M. oreades 
was present in the best mixtures, while C. cibarius was present in the worst ones 
(Queirós et al., 2009). According to Vieira et al. (2012), reducing or scavenging 
properties require different proportions of mushrooms and the effect obtained after 
mixing different percentages depends on the used proportions. Regarding combinations 
of different dietary supplements (pills, capsules or bags with labeled antioxidant effects) 
performed by Almeida et al. (2011), the synergistic interaction was also the main 
observed effect. Similar results were obtained in a study involving plant (fennel, lemon-
verbena and spearmint) infusions and decoctions (Guimarães et al., 2011), concluding 
that these preparations are in fact more effective as mixtures than individually. 
Nevertheless, as far as we know, there are no studies involving syrups interaction that 
clarify their effect (synergistic, additive or antagonist) in the antioxidant and anti-
hepatocellular carcinoma activity. The syrup of borututu is indicated to detoxify and 
purify the organism, to relieve liver disorders and is also known for its potential 
antiviral effect; artichoke syrup is used in cases of fluid retention or malfunction of the 
liver and gallbladder, and milk thistle syrup is applied in cases of poor digestion, fatty 
liver, jaundice, poisoning and biliary lithiasis (Longe, 2005). Due to their benefits, the 
three plants are also combined in syrups available in the market that claim to have 
beneficial effects in liver, stomach, spleen and the entire urinary tract diseases acting as 
detoxifiers and cleansers of the whole body, being very diuretic and efficient in 
removing grease and weight reduction (Longe, 2005). Thus, the combined syrup can be 
helpful in the treatment of health problems where the individual plants cannot act, and 
in those cases there are, indeed, synergistic effects.  
 
Overall, MS proved to be the most potent syrup, giving support to the use of individual 
syrups for antioxidant and anti-hepatocellular carcinoma purposes; nevertheless, AS 
was highly favored when mixed with the other plants highlighting, in this case, the 
importance of syrups based on mixed plants. Synergistic effects were the main 
interactions observed in the mixture of artichoke, borututu and milk thistle; mixing the 
syrups based on each single plant proved to be more efficient regarding antioxidant 
proposals that mixing plants in the same syrup. The latter was advantageous for anti-
hepatocellular carcinoma activity. Among the three studied plants, borututu infusion 
(Pereira et al., 2013) and milk thistle syrup (herein studied) gave the best results in the 
antioxidant activity with similar EC50 values of 0.02 to 0.32 mg/mL and 0.02 to 0.62 
mg/mL, respectively, but regarding the capacity to inhibit the proliferation of HepG2 
cell line, the infusion showed best results (GI50=146 µg/mL) than the syrup (GI50=280 
µg/mL). Thus, to achieve the mentioned benefits of these plants, it seems unnecessary 
to acquire expensive syrups instead of the infusions, unless there are other benefits 
besides the herein reported, associated to the syrups. 
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Table 1. Antioxidant activity and hepatotoxicity of artichoke, borututu and milk thistle 
syrups (mean ± SD). 
 
 AS BS MS Positive control* 
Antioxidant activity (EC50 values, mg/mL) 
DPPH scavenging activity  225.27 ± 9.76a 1.34 ± 0.06b 0.32 ± 0.01c 0.04 ± 0.00 
Reducing power  73.15 ± 0.19a 1.06 ± 0.00b 0.05 ± 0.00c 0.03 ± 0.00 
β-carotene bleaching inhibition  17.38 ± 0.38a 0.51 ± 0.04b 0.02 ± 0.00c 0.003 ± 0.00 
TBARS inhibition  21.26 ± 0.04a 0.15 ± 0.00b 0.05 ± 0.00c 0.004 ± 0.00 
Anti-hepatocellular carcinoma activity  (GI50 values, µg/mL) 
HepG2 (hepatocellular carcinoma) n.a. n.a. 280.48 ± 18.14 1.44 ± 0.02 
Hepatotoxicity (GI50 values, µg/mL) 
PLP2 (non-tumour liver primary culture) n.a. n.a. n.a. 2.14 ± 0.01 
AS- artichoke syrup; BS- borututu syrup; MS- milk thistle syrup.  
*Trolox and ellipticine for antioxidant and hepatotoxicity assays, respectively. EC50 
values correspond to the sample concentration achieving 50% of antioxidant activity or 
0.5 of absorbance in reducing power assay. GI50 values correspond to the sample 
concentration achieving 50% of growth inhibition in human tumour cell lines or in liver 
primary culture PLP2.  
n.a.- no activity up to 400 µg/mL. 





Table 2. Antioxidant activity and hepatotoxicity of syrups containing the three plants 
(artichoke, borututu and milk thistle) (mean ± SD). 
 
  (A+B+M)S AS+BS+MS 
 Theoretical Experimental Effect Experimental Effect 
Antioxidant activity (EC50 values, mg/mL) 
DPPH scavenging activity  52.29 5.77 ± 0.02a SN 2.16 ± 0.02b SN 
Reducing power  17.10 4.14 ± 0.06a SN 0.78 ± 0.01b SN 
β-carotene bleaching inhibition  4.13 1.36 ± 0.02b SN 7.13 ± 0.23a AN 
TBARS inhibition  4.95 0.60 ± 0.02a SN 0.25 ± 0.01b SN 
Anti-hepatocellular carcinoma activity  (GI50 values, µg/mL) 
HepG2 (hepatocellular carcinoma) 280.48 342.30 ± 27.39 AN n.a. AN 
Hepatotoxicity (GI50 values, µg/mL) 
PLP2 (non-tumour liver primary culture) n.a. n.a. - n.a. - 
  
AD- additive effect; SN- synergistic effect; AN- antagonistic (negative synergistic) 
effect. 
n.a.- no activity up to 400 µg/mL. 
Different letters in each row mean significant differences between the experimental 
EC50 values (p<0.05). 
 
 
